Insiders · Profile

LEWIS JOEL

President and CEO at GALECTIN THERAPEUTICS. Filing since 25 Jun 2018. CIK 0001725595

Company
Date
Role
Action
Shares
Amount
Of holding
6 Jan 2026
President and CEO
Sold on a plan
37,698
$134.85K
4.3%
5 Jan 2026
President and CEO
Sold on a plan
27,731
$108.34K
3.1%
2 Jan 2026
President and CEO
Sold on a plan
18,571
$77.94K
2.0%
17 Dec 2025
President and CEO
Sold on a plan
7,829
$55.24K
0.9%
18 Nov 2025
President and CEO
Sold on a plan
6,783
$41.72K
0.8%
17 Nov 2025
President and CEO
Sold on a plan
15,680
$94.64K
1.8%
10 Nov 2025
President and CEO
Sold on a plan
1,867
$11.25K
0.2%
5 Nov 2025
President and CEO
Sold on a plan
200
$1.20K
0.0%
4 Nov 2025
President and CEO
Sold on a plan
14,420
$87.53K
1.7%
3 Nov 2025
President and CEO
Sold on a plan
1,300
$7.81K
0.2%
12 Sep 2025
President and CEO
Sold on a plan
14,000
$89.05K
1.7%
23 Dec 2024
President and CEO
Sold on a plan
56,000
$49.61K
5.9%
24 Apr 2024
President and CEO
Bought
1,000
$3.39K
100%
16 Feb 2023
President and CEO
Bought
1,000
$1.52K
opened
31 May 2019
Director
Bought
12,849
$54.99K
19.5%
5 Apr 2019
Director
Bought
667
$3.21K
1.0%
7 Feb 2019
Director
Bought
1,000
$4.48K
1.6%
29 Jan 2019
Director
Bought
1,000
$4.81K
1.6%
25 Jun 2018
Director
Bought
1,000
$7.06K
2.0%
19 decisions on file.